retatrutide clinic weight loss treatment at The Piedmont Retatrutide for Weight Loss: TRIUMPH-1

A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer

Eur J Pharmacol 842:125132 Ishii Y, Fujii Y, Mimura C, Umezawa H (1975) Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor

So, in summary: FOXO4-DRI appears to represent the next-generation senolytic, offering improved specificity, but it is still earlier stage than many small-molecule senolytics or repurposed drug combinations

The most dominant zeitgeber is the light-dark cycle, although other factors such as feeding times, temperature changes, and social cues also contribute 16